Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
BOSTON and TEL AVIV, Israel, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Quris-AI , an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, announced the addition of Michel Vounatsos, former CEO of Biogen, to its Board of Directors, and the appointment of Yossi Ben Amram, former Merck & Co., Inc. (MSD) Regional President, as President of Quris-AI.
- BOSTON and TEL AVIV, Israel, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Quris-AI , an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, announced the addition of Michel Vounatsos, former CEO of Biogen, to its Board of Directors, and the appointment of Yossi Ben Amram, former Merck & Co., Inc. (MSD) Regional President, as President of Quris-AI.
- “Adding accomplished pharmaceutical leaders such as Yossi Ben Amram and Michel Vounatsos to our leadership team will be invaluable in our push for a pharma Bio-AI revolution.
- Michel Vounatsos brings extensive global leadership and management experience in the biopharmaceutical industry, including having served as CEO and member of the Board of Directors of Biogen, Inc. from early 2017 until November 2022.
- Vounatsos earned his MBA from the HEC School of Management in Paris, France, and his C.S.C.T.